Promethazine Hydrochloride Injection — FDA Drug Shortage

Current — Hikma Pharmaceuticals USA, Inc.

The FDA lists a drug shortage record for Promethazine Hydrochloride Injection (injection) from Hikma Pharmaceuticals USA, Inc. with status Current. The shortage was first posted on Nov 21, 2023.

Shortage details

Status
Current
Company
Hikma Pharmaceuticals USA, Inc.
Package NDC
0641-0928-25
Dosage Form
Injection
Presentation
Promethazine Hydrochloride, Injection, 25 mg/1 mL (NDC 0641-0928-25)
Initial Posting
Nov 21, 2023

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.